World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

Login Register
World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

SJIF Impact Factor: 6.842

Abstract

THE EVALUATION OF ESTROGEN AND PROGESTERONE HORMONES LEVELS IN PRE AND POSTMENOPAUSAL BREAST CANCER WOMEN

*Ahmed T. Ahmed and Enas H. Hameed

ABSTRACT

The level of Estrogen hormone was decreased significantly in total breast cancer patients, premenopausal and postmenopausal compare with control, while the level of Progesterone hormone increased significantly in breast cancer patients of all stages compare to control group. Serum samples were collected from 140 women were ,50 of these women were control and 90 women were breast cancer patients attending to cancer center in Erbil city from Jaunary 2017 to Augest 2017.Study populations classified into three groups which age ranged from (29-65) years, total subjects, pre and postmenopausal women. The results of estrogen hormone (E.H) were showed a highly significant decrease (P?0.01) in total and (pre and postmenopausal) breast cancer patients compare with healthy control. While the results of P.H were showed a highly significant increase (P?0.01) in total breast cancer patients compare with healthy control and the results showed that there was no significant difference (P?0.05) in Premenopausal and Postmenopausal of breast cancer women compare with control.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR